GDRX
GoodRx Holdings Inc

5,965
Mkt Cap
$695.43M
Volume
3.46M
52W High
$5.81
52W Low
$1.77
PE Ratio
24.11
GDRX Fundamentals
Price
$2.03
Prev Close
$2.15
Open
$2.17
50D MA
$2.35
Beta
1.34
Avg. Volume
4.21M
EPS (Annual)
$0.0853
P/B
1.12
Rev/Employee
$1.14M
$1,248.38
Loading...
Loading...
News
all
press releases
HIMS Expands Personalized Digital Healthcare Access and Services
Hims & Hers expands its digital care platform with labs tracking, multi-cancer screening access and broader treatments as it scales personalized healthcare globally.
Zacks·6d ago
News Placeholder
More News
News Placeholder
Lakewood Capital Management LP Decreases Position in GoodRx Holdings, Inc. $GDRX
Lakewood Capital Management LP reduced its position in shares of GoodRx Holdings, Inc. (NASDAQ:GDRX - Free Report) by 64.1% in the 3rd quarter, according to the company in its most recent 13F filing...
MarketBeat·8d ago
News Placeholder
GoodRx (NASDAQ:GDRX) Shares Down 6% - Time to Sell?
GoodRx (NASDAQ:GDRX) Trading Down 6% - Here's What Happened...
MarketBeat·11d ago
News Placeholder
GoodRx Partners with Viatris to Offer Up to 85% Savings on Established Brand Medications
GoodRx (Nasdaq: GDRX), the leading platform for prescription savings in the U.S., today announced a new collaboration with Viatris, a global healthcare company, to make 17 of its established brand...
Business Wire·11d ago
News Placeholder
GoodRx to Expand Employer-Sponsored Access to Zepbound KwikPen
GoodRx (Nasdaq: GDRX), the leading platform for prescription savings in the U.S., today announced employer-sponsored access to Zepbound (tirzepatide) KwikPen (for single-patient-use) through GoodRx...
Business Wire·16d ago
News Placeholder
Wells Fargo & Company Has Lowered Expectations for GoodRx (NASDAQ:GDRX) Stock Price
Wells Fargo & Company reduced their price target on shares of GoodRx from $7.00 to $3.50 and set an "overweight" rating on the stock in a research report on Wednesday...
MarketBeat·18d ago
News Placeholder
Citigroup Lowers GoodRx (NASDAQ:GDRX) Price Target to $3.50
Citigroup dropped their target price on shares of GoodRx from $4.50 to $3.50 and set a "buy" rating for the company in a research report on Tuesday...
MarketBeat·19d ago
News Placeholder
GoodRx (NASDAQ:GDRX) Trading Up 9.4% - Should You Buy?
GoodRx (NASDAQ:GDRX) Trading 9.4% Higher - Should You Buy...
MarketBeat·20d ago
News Placeholder
The Goldman Sachs Group Lowers GoodRx (NASDAQ:GDRX) Price Target to $2.50
The Goldman Sachs Group reduced their target price on GoodRx from $4.00 to $2.50 and set a "neutral" rating for the company in a report on Monday...
MarketBeat·20d ago
News Placeholder
GoodRx (NASDAQ:GDRX) Given New $3.00 Price Target at Mizuho
Mizuho cut their price objective on GoodRx from $4.00 to $3.00 and set a "neutral" rating for the company in a research report on Friday...
MarketBeat·23d ago
<
1
2
...
>

Latest GDRX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.